Serial Number | 97675888 |
Word Mark | GENOFIT |
Filing Date | Monday, November 14, 2022 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Monday, December 18, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids, tissue, and DNA for use in disease detection, namely, food sensitivities, allergies, intolerances, nutrition, fitness, and wellness |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, November 17, 2022 |
Primary Code | 005 |
First Use Anywhere Date | Wednesday, October 9, 2019 |
First Use In Commerce Date | Wednesday, October 9, 2019 |
Party Name | Genofit Lifesciences Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | VANCOUVER, BC V5R5V1 CA |
Event Date | Event Description |
Monday, December 18, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Monday, December 18, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Monday, December 18, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Friday, September 1, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Friday, September 1, 2023 | NON-FINAL ACTION E-MAILED |
Friday, September 1, 2023 | NON-FINAL ACTION WRITTEN |
Monday, August 28, 2023 | ASSIGNED TO EXAMINER |
Thursday, November 17, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, November 17, 2022 | NEW APPLICATION ENTERED |